Pub. Date : 2011 Sep 1
PMID : 21810677
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | INTRODUCTION: Retrospective studies suggest that p53 alteration is prognostic for recurrence in patients with urothelial bladder cancer and predictive for benefit from combination methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) adjuvant chemotherapy. | Methotrexate | tumor protein p53 | Homo sapiens |